This inventor holds 3 USPTO granted patents. Top assignees: Pharma Mar, S.a., University of Illinois. Active years: 2001-2006.
Company Filing History:
Years Active: 2001-2006
Title: Pablo Floriano: Innovator in Ecteinascidin Research
Introduction
Pablo Floriano is a notable inventor based in Madrid, Spain. He has made significant contributions to the field of biochemistry, particularly in the study of ecteinascidin 743. With a total of 3 patents to his name, Floriano's work has advanced our understanding of this important compound.
Latest Patents
Floriano's latest patents focus on the metabolites of ecteinascidin 743. His research includes the purification and structure elucidation of several products of the metabolism of Et 743 by human cytochrome CYP3A4. These compounds are abbreviated as 'ETM' followed by a numeric value representing their approximate molecular weight. To date, three compounds have been identified: ETM 305, ETM 775, and ETM 204. The structures of these ecteinascidin metabolites are crucial for further research and application.
Career Highlights
Throughout his career, Floriano has worked with prominent organizations such as Pharma Mar and the University of Illinois. His experience in these institutions has allowed him to collaborate with leading experts in the field, enhancing his research capabilities and contributions.
Collaborations
Some of Floriano's notable coworkers include Kenneth L. Rinehart and Lola Garcia Gravalos. Their collaborative efforts have played a significant role in advancing the research on ecteinascidin and its metabolites.
Conclusion
Pablo Floriano's innovative work in the field of ecteinascidin research has led to important discoveries and advancements. His contributions continue to influence the scientific community and pave the way for future research in this area.